医药-话题@MedSci

#医药#

1668篇内容 | 2732人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=新华社：数字医疗步入成熟，医药电商将进入细分化、定制化阶段, objectType=article, longId=206879, objectId=1b1b2068e90f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b1b2068e90f, replyNumber=0, likeNumber=67, createdTime=2021-02-08, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b1b2068e90f, moduleTitle=新华社：数字医疗步入成熟，医药电商将进入细分化、定制化阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b1b2068e90f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410103, encodeId=72a0141010305, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=数字医疗步入成熟，医药电商将进入细分化、定制化阶段, objectType=article, longId=206806, objectId=5f5c206806bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5c206806bd, replyNumber=0, likeNumber=50, createdTime=2021-02-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5c206806bd, moduleTitle=数字医疗步入成熟，医药电商将进入细分化、定制化阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5c206806bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410102, encodeId=2f0714101027e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=广西中医药大学原校长唐农、副校长覃裕旺被“双开”, objectType=article, longId=206696, objectId=cb6b206696c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb6b206696c7, replyNumber=0, likeNumber=65, createdTime=2021-02-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb6b206696c7, moduleTitle=广西中医药大学原校长唐农、副校长覃裕旺被“双开”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb6b206696c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410100, encodeId=60591410100b9, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=新形势下中国医药研发的现状和趋势, objectType=article, longId=206423, objectId=9b6620642395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6620642395, replyNumber=0, likeNumber=95, createdTime=2021-01-31, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6620642395, moduleTitle=新形势下中国医药研发的现状和趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b6620642395)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410099, encodeId=90f7141009961, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=关于医药行业项目管理，你不得不知道的几件事, objectType=article, longId=206289, objectId=2f8220628973, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f8220628973, replyNumber=0, likeNumber=75, createdTime=2021-01-28, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f8220628973, moduleTitle=关于医药行业项目管理，你不得不知道的几件事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f8220628973)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410098, encodeId=526114100981f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=丹诺医药牵手强生，共同合作开发非结核分支杆菌新药, objectType=article, longId=205872, objectId=737b2058e2c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=737b2058e2c9, replyNumber=0, likeNumber=55, createdTime=2021-01-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=737b2058e2c9, moduleTitle=丹诺医药牵手强生，共同合作开发非结核分支杆菌新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=737b2058e2c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410097, encodeId=961e141009e93, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=为不凡速度点赞！和黄医药重磅肿瘤新药苏泰达®获批发货仅用半月, objectType=article, longId=205754, objectId=c928205e5414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c928205e5414, replyNumber=0, likeNumber=52, createdTime=2021-01-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c928205e5414, moduleTitle=为不凡速度点赞！和黄医药重磅肿瘤新药苏泰达®获批发货仅用半月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c928205e5414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410101, encodeId=30d81410101ec, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究, objectType=article, longId=205651, objectId=d0492056511e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0492056511e, replyNumber=0, likeNumber=62, createdTime=2021-01-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0492056511e, moduleTitle=精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0492056511e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410096, encodeId=868914100960d, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=恒瑞医药「甲磺酸阿帕替尼片」新适应症获批：治疗肝细胞癌, objectType=article, longId=205576, objectId=70432055e6e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70432055e6e8, replyNumber=0, likeNumber=61, createdTime=2021-01-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70432055e6e8, moduleTitle=恒瑞医药「甲磺酸阿帕替尼片」新适应症获批：治疗肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70432055e6e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410095, encodeId=dca614100954a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=从AI研发到智能制造，如何抓住生物医药产业机遇“智驱未来”？, objectType=article, longId=205324, objectId=2eab205324ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eab205324ea, replyNumber=0, likeNumber=53, createdTime=2021-01-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eab205324ea, moduleTitle=从AI研发到智能制造，如何抓住生物医药产业机遇“智驱未来”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eab205324ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410094, encodeId=c3ca141009411, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=Nature：自然杂志公布2020年十大重要科学发现，5项与生物医药相关, objectType=article, longId=204693, objectId=f400204693b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f400204693b8, replyNumber=0, likeNumber=100, createdTime=2020-12-21, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f400204693b8, moduleTitle=Nature：自然杂志公布2020年十大重要科学发现，5项与生物医药相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f400204693b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410093, encodeId=147b141009391, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=康复新液为何能获选“十三五中国医药科技标志性成果”？, objectType=article, longId=204618, objectId=2208204618dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2208204618dc, replyNumber=0, likeNumber=70, createdTime=2020-12-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2208204618dc, moduleTitle=康复新液为何能获选“十三五中国医药科技标志性成果”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2208204618dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=康复新液入榜2020“中国医药•品牌榜”, objectType=article, longId=204598, objectId=171020459835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=171020459835, replyNumber=0, likeNumber=78, createdTime=2020-12-18, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=171020459835, moduleTitle=康复新液入榜2020“中国医药•品牌榜”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=171020459835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410092, encodeId=40941410092ff, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=恒瑞医药PARP抑制剂获批上市, objectType=article, longId=204504, objectId=4eb920450478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eb920450478, replyNumber=0, likeNumber=89, createdTime=2020-12-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eb920450478, moduleTitle=恒瑞医药PARP抑制剂获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eb920450478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410090, encodeId=dd51141009005, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=和铂医药今日港交所上市：手握稀缺抗体平台，在研新药前途光明, objectType=article, longId=204419, objectId=e5eb2044196e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5eb2044196e, replyNumber=0, likeNumber=51, createdTime=2020-12-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5eb2044196e, moduleTitle=和铂医药今日港交所上市：手握稀缺抗体平台，在研新药前途光明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5eb2044196e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410089, encodeId=98b51410089da, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药人员全新工资水平公布, objectType=article, longId=204298, objectId=c506204298ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c506204298ed, replyNumber=0, likeNumber=55, createdTime=2020-12-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c506204298ed, moduleTitle=医药人员全新工资水平公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c506204298ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410088, encodeId=ac6c141008803, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=欧洁重磅新品火热上市，开启生物医药洁净解决方案新时代, objectType=article, longId=204259, objectId=27592042592c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27592042592c, replyNumber=0, likeNumber=75, createdTime=2020-12-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27592042592c, moduleTitle=欧洁重磅新品火热上市，开启生物医药洁净解决方案新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27592042592c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410087, encodeId=4c8e141008e01, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药荣获Scrip“更佳合同研究组织”称号, objectType=article, longId=204244, objectId=6a862042443b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a862042443b, replyNumber=0, likeNumber=57, createdTime=2020-12-08, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a862042443b, moduleTitle=精鼎医药荣获Scrip“更佳合同研究组织”称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a862042443b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410086, encodeId=709a1410086fc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=网售处方药“开闸”：千亿医药电商市场再掀波澜, objectType=article, longId=204184, objectId=e159204184e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e159204184e7, replyNumber=0, likeNumber=74, createdTime=2020-12-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e159204184e7, moduleTitle=网售处方药“开闸”：千亿医药电商市场再掀波澜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e159204184e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410085, encodeId=626e14100853c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=湖南中医药大学第一附属医院谢小兵主任：POCT核酸检测在临床应用大有可为, objectType=article, longId=204171, objectId=9ec72041e1c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ec72041e1c7, replyNumber=0, likeNumber=58, createdTime=2020-12-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ec72041e1c7, moduleTitle=湖南中医药大学第一附属医院谢小兵主任：POCT核酸检测在临床应用大有可为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ec72041e1c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

智慧医人 (审核中...)

前往app查看评论内容

#医药#

新华社：数字医疗步入成熟，医药电商将进入细分化、定制化阶段

2021-02-08

cathymary (审核中...)

前往app查看评论内容

#医药#

数字医疗步入成熟，医药电商将进入细分化、定制化阶段

2021-02-07

cathymary (审核中...)

前往app查看评论内容

#医药#

广西中医药大学原校长唐农、副校长覃裕旺被“双开”

2021-02-04

cathymary (审核中...)

前往app查看评论内容

#医药#

新形势下中国医药研发的现状和趋势

2021-01-31

cathymary (审核中...)

前往app查看评论内容

#医药#

关于医药行业项目管理，你不得不知道的几件事

2021-01-28

cathymary (审核中...)

前往app查看评论内容

#医药#

丹诺医药牵手强生，共同合作开发非结核分支杆菌新药

2021-01-20

cathymary (审核中...)

前往app查看评论内容

#医药#

为不凡速度点赞！和黄医药重磅肿瘤新药苏泰达®获批发货仅用半月

2021-01-16

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药任命克莱尔·格雷斯为公司首席患者官，将助力推进以“患者为中心”的临床研究

2021-01-13

cathymary (审核中...)

前往app查看评论内容

#医药#

恒瑞医药「甲磺酸阿帕替尼片」新适应症获批：治疗肝细胞癌

2021-01-11

cathymary (审核中...)

前往app查看评论内容

#医药#

从AI研发到智能制造，如何抓住生物医药产业机遇“智驱未来”？

2021-01-06

cathymary (审核中...)

前往app查看评论内容

#医药#

Nature：自然杂志公布2020年十大重要科学发现，5项与生物医药相关

2020-12-21

hb2008ye (审核中...)

前往app查看评论内容

#医药#

康复新液为何能获选“十三五中国医药科技标志性成果”？

2020-12-19

cathymary (审核中...)

前往app查看评论内容

#医药#

康复新液入榜2020“中国医药•品牌榜”

2020-12-18

cathymary (审核中...)

前往app查看评论内容

#医药#

恒瑞医药PARP抑制剂获批上市

2020-12-16

cathymary (审核中...)

前往app查看评论内容

#医药#

和铂医药今日港交所上市：手握稀缺抗体平台，在研新药前途光明

2020-12-13

cathymary (审核中...)

前往app查看评论内容

#医药#

医药人员全新工资水平公布

2020-12-09

cathymary (审核中...)

前往app查看评论内容

#医药#

欧洁重磅新品火热上市，开启生物医药洁净解决方案新时代

2020-12-09

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药荣获Scrip“更佳合同研究组织”称号

2020-12-08

cathymary (审核中...)

前往app查看评论内容

#医药#

网售处方药“开闸”：千亿医药电商市场再掀波澜

2020-12-07

cathymary (审核中...)

前往app查看评论内容

#医药#

湖南中医药大学第一附属医院谢小兵主任：POCT核酸检测在临床应用大有可为

2020-12-07

科室
- - 订阅+
  - 更多科室
工具
服务